Case study and panel discussion.
Maki
Dennis G
DG
Section of Infectious Diseases, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.
Ebert
Steven C
SC
Rybak
Michael J
MJ
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002506:Cephalexin / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006801:Humans; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D002981:Clindamycin; D002506:Cephalexin